Monday, December 09, 2019 1:58:53 PM
I certainly hope you're right, but sustaining a $5 billion market cap, so as to attract an even bigger buyout price, isn't something I've previously observed prior to FDA approval in other companies. A few billion, yes, even more with a partnership, but I believe $5 billion or more with neither partnership or FDA approval is certainly a reasonable high, but I find it hard to believe it will be sustained. It could easily be exceeded with either a partnership, or regulatory approval anywhere, as both would begin to initiate substantial funding and earnings.
I really cannot say if regulators other than the FDA can act dramatically faster, but I'd be very surprised to see FDA action before the end of next year, at the earliest, if a BLA is filed by mid year.
I don't believe a buyout can be a large multiple of an emotional high, but it can be at a sustained high. If a price of $5 is sustained, a $15 buyout could be reasonable, just a little more than that and you have $20, but that's the extreme. Most buyouts aren't more than double the current price, and many are less than 50% above the current price.
It's my belief that a company looking to acquire another company where the price is agreed on will help boost the stock price toward that price to not be viewed as overpaying for what they purchased. A BP would be chastised by its shareholders if it bid 5 times what a company was selling for, but if that company rose to half the offering price in a matter of days or weeks before the offer, it would be no problem. I still believe more about Direct is needed to bring numbers like $20 billion, but that could be possible in a year or so.
Gary
Recent NWBO News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM